|
MCM10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.47589999613496E-08 |
| Normal-vs-Stage2 |
4.166000E-02 |
| Normal-vs-Stage3 |
7.6379999999987E-05 |
| Normal-vs-Stage4 |
7.661700E-03 |
| Stage1-vs-Stage2 |
5.987200E-01 |
| Stage1-vs-Stage3 |
3.961200E-03 |
| Stage1-vs-Stage4 |
4.728000E-02 |
| Stage2-vs-Stage3 |
5.811800E-02 |
| Stage2-vs-Stage4 |
9.716000E-02 |
| Stage3-vs-Stage4 |
9.972600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.23692200715686E-13 |
| Normal-vs-AfricanAmerican |
1.803700E-04 |
| Normal-vs-Asian |
6.669600E-02 |
| Caucasian-vs-AfricanAmerican |
9.044800E-01 |
| Caucasian-vs-Asian |
6.151600E-01 |
| AfricanAmerican-vs-Asian |
6.759600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.97695243193175E-13 |
| Normal-vs-Female |
5.70149999989944E-07 |
| Male-vs-Female |
9.979500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.24409999999687E-05 |
| Normal-vs-Extreme_Weight |
3.86130000196161E-08 |
| Normal-vs-Obese |
3.82939999999943E-05 |
| Normal-vs-Extreme_Obese |
2.227800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.543970E-01 |
| Normal_Weight-vs-Obese |
5.166200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.996700E-03 |
| Extreme_Weight-vs-Obese |
4.904000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.781890E-02 |
| Obese-vs-Extreme_Obese |
1.758010E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.617000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.439499713347E-10 |
| Normal-vs-Age(61-80Yrs) |
1.92070000015754E-07 |
| Normal-vs-Age(81-100Yrs) |
9.630500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.973700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.021500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.914310E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.278010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.438100E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.028400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.45910003471295E-09 |
| Normal-VS-Type2 PRCC |
3.91600000204662E-08 |
| Normal-VS-KIRP CIMP |
1.482130E-03 |
| Normal-VS-Unclassified PRCC |
3.65239999999822E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.230400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.377400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.292600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.236600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.128400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.460500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.26019999999872E-05 |
| Normal-vs-N1 |
1.044710E-04 |
| Normal-vs-N2 |
1.376410E-01 |
| N0-vs-N1 |
2.299400E-03 |
| N0-vs-N2 |
2.604200E-01 |
| N1-vs-N2 |
7.403800E-01 |
|
|
